Manijeh N Goldberg
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$15.5MFederal grants as PI18 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
18 awards · $15.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 18, 2026 | NIH | SBIR Phase II Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer) | $1.2M | PRIVO TECHNOLOGIES, LLC |
| Jun 25, 2025 | NIH | SBIR Phase II Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer) | $1.2M | PRIVO TECHNOLOGIES, LLC |
| Jun 14, 2024 | NIH | SBIR Phase II Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer) | $2.1M | PRIVO TECHNOLOGIES, LLC |
| Apr 3, 2024 | NIH | SBIR Phase II Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings | $1.0M | PRIVO TECHNOLOGIES, LLC |
| Mar 27, 2023 | NIH | SBIR Phase II Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings | $987K | PRIVO TECHNOLOGIES, LLC |
| Jan 5, 2023 | NIH | SBIR Phase II Commercialization of Safe and Effective Locoregional Head and Neck Cancer Therapy | $985K | PRIVO TECHNOLOGIES, LLC |
| Feb 24, 2022 | NIH | SBIR Phase II Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings | $401K | PRIVO TECHNOLOGIES, LLC |
| Jan 10, 2022 | NIH | SBIR Phase II Commercialization of Safe and Effective Locoregional Head and Neck Cancer Therapy | $779K | PRIVO TECHNOLOGIES, LLC |
| Jun 22, 2020 | NIH | SBIR Phase II Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer | $1.0M | PRIVO TECHNOLOGIES, LLC |
| Jul 19, 2019 | NIH | SBIR Phase II Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer | $4K | PRIVO TECHNOLOGIES, LLC |
| Jun 24, 2019 | NIH | SBIR Phase II Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer | $1.1M | PRIVO TECHNOLOGIES, LLC |
| Jan 11, 2019 | NIH | SBIR Phase II Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer | $98K | PRIVO TECHNOLOGIES, LLC |
| Feb 17, 2017 | NIH | SBIR Phase II Customized Nanotechnology Based Treatment of Oral Cancer | $1000K | PRIVO TECHNOLOGIES, LLC |
| Feb 1, 2017 | NIH | SBIR Phase II FAST TRACK: IND Enabling Studies for Oral Cancer | $1.2M | PRIVO TECHNOLOGIES, LLC |
| Aug 17, 2016 | NIH | SBIR Phase II Customized Nanotechnology Based Treatment of Oral Cancer | $265K | PRIVO TECHNOLOGIES, LLC |
| Feb 24, 2016 | NIH | SBIR Phase II Customized Nanotechnology Based Treatment of Oral Cancer | $1000K | PRIVO TECHNOLOGIES, LLC |
| Jan 13, 2016 | NIH | SBIR Phase II FAST TRACK: IND Enabling Studies for Oral Cancer | $961K | PRIVO TECHNOLOGIES, LLC |
| Jun 12, 2015 | NIH | SBIR Phase II FAST TRACK: IND Enabling Studies for Oral Cancer | $293K | PRIVO TECHNOLOGIES, LLC |
Peer ranks
Federal funding#21
Awards as PI#39
Patents#505
Companies
- PRIVO TECHNOLOGIES, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.